GenoMethods - Biotechnology, Bioinformatics & AI in Biology

Sun Pharma plans $1 billion rupee bond to replace Organon deal loan

Sun Pharmaceutical Industries is lining up a 100 billion rupee bond sale to pay down its bridge loan for the Organon & Co. buyout. Rising US yields are pushing Indian firms like Sun Pharma to borrow at home.

By Vivian Lin · September 30, 2026, 12:33 PM · 2 mins read

Biotechnology News & Analysis

Uzbekistan launches DOST brand as first national car project moves forward

By Adrian Cole

AI in Biology

AI platform for omics data earns top genomics award in Seoul

By Adrian Cole

Biotechnology News & Analysis

PTU brings TUM’s bioinformatics and biomedical engineering to Uzbekistan

By Adrian Cole

Clinical Trials & Evidence

HIV positive cancer patients face longer journeys for CAR-T clinical trial access

By Elena MacLeod

IN-DEPTH REPORTING

Clinical Trials & Evidence

Novo Nordisk grabs UBT251 rights to keep lead in obesity drug race

Novo Nordisk is doubling down on obesity drugs after landing global rights to UBT251, a triple-agonist from China that cut nearly 20 percent of body weight in Phase 2 trials.

By Vivian Lin · September 30, 2026, 7:05 AM

Clinical Trials & Evidence

China takes the lead in in vivo CAR-T trials as global biotech eyes shift

September 30, 2026, 9:07 AM

Clinical Trials & Evidence

CAR T cell therapy triggers remission in severe rheumatoid arthritis

September 30, 2026, 8:37 AM

BIOTECHNOLOGY NEWS & ANALYSIS >

Clinical Trials & Evidence

Curocell pushes for fast Rimkato launch as insurance decision nears

Curocell is moving fast to get National Health Insurance coverage for Rimkato, Korea's first CAR-T therapy. The company promises quick delivery and aims to prove cell therapy can work as a real business.

By Elena MacLeod · September 28, 2026, 9:03 PM

AI in Biology

AI agent spots viral DNA repeats that mirror CRISPR

September 27, 2026, 9:24 PM

Drug Discovery

Ulefnersen slows ALS decline in pivotal FUS gene trial

September 27, 2026, 10:51 AM

Biotechnology, Decoded

GenoMethods explains biotechnology from method to medicine to market, connecting scientific evidence, clinical development, companies and the technologies shaping future health.

TOP STORIES

Sun Pharma plans $1 billion rupee bond to replace Organon deal loan

Uzbekistan launches DOST brand as first national car project moves forward

AI platform for omics data earns top genomics award in Seoul

PTU brings TUM’s bioinformatics and biomedical engineering to Uzbekistan

HIV positive cancer patients face longer journeys for CAR-T clinical trial access

IN-DEPTH REPORTING

Novo Nordisk grabs UBT251 rights to keep lead in obesity drug race

China takes the lead in in vivo CAR-T trials as global biotech eyes shift

CAR T cell therapy triggers remission in severe rheumatoid arthritis

FEATURED STORIES

CAR T cells clear the way for kidney transplants in highly sensitized patients

Alberta puts $1 million behind new genomics placements for small biotech firms

AVS Bio snaps up Biorbyt to boost biomaterials and digital reach

Patients reclaim their future as gene and cell therapies rewrite cancer treatment

GM crops credited with huge farm profits and lower emissions over 30 years

AI agent slashes millions from clinical trial costs

BIOTECHNOLOGY NEWS & ANALYSIS >

Curocell pushes for fast Rimkato launch as insurance decision nears

Colossal delays mammoth project as gene editing proves tougher than expected

HLB gets FDA green light for Refiktu in bile duct cancer

CLINICAL TRIALS & EVIDENCE >

Colossal Biosciences delays woolly mammoth comeback to 2030s

AI agent spots viral DNA repeats that mirror CRISPR

Ulefnersen slows ALS decline in pivotal FUS gene trial

Biotechnology, Decoded